Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jul 27, 2025; 17(7): 105956
Published online Jul 27, 2025. doi: 10.4240/wjgs.v17.i7.105956
Published online Jul 27, 2025. doi: 10.4240/wjgs.v17.i7.105956
Table 1 Clinical characteristics of included patients, n (%)
All cohort (n = 102) | Non-ITIN (n = 54) | ITIN (n = 48) | t/χ2 | P value | |
Age, years | 70.00 ± 13.33 | 66.50 ± 13.72 | 73.94 ± 11.82 | -2.914 | 0.004 |
Sex, male | 54 (52.9) | 32 (59.3) | 22 (45.8) | 1.839 | 0.175 |
Complication | |||||
Hypertension | 50 (49.0) | 27 (50.0) | 23 (47.9) | 0.044 | 0.834 |
Diabetes | 16 (15.7) | 9 (16.7) | 7 (14.6) | 0.083 | 0.773 |
Heart disease | 51 (50.0) | 25 (46.3) | 26 (54.2) | 0.630 | 0.427 |
History of cerebrovascular disease | 16 (15.7) | 8 (14.8) | 8 (16.7) | 0.066 | 0.797 |
Scanning mode | 0.123 | 0.725 | |||
DECT | 47 (46.1) | 24 (44.4) | 23 (47.9) | ||
Conventional MDCT | 55 (53.9) | 30 (55.6) | 25 (52.1) | ||
Vascular involvement | 3.970 | 0.137 | |||
SMA | 62 (60.8) | 33 (61.1) | 29 (60.4) | ||
SMV | 29 (28.4) | 18 (33.3) | 11 (22.9) | ||
SMA + SMV | 11 (10.8) | 3 (5.6) | 8 (16.7) |
Table 2 The consistency of subjective computed tomography signs between radiologists A and B
CT signs | Kappa (95%CI) | P value |
Intestinal wall thickening | 0.781 (0.646, 0.898) | < 0.001 |
Reduced or absent bowel wall enhancement | 0.739 (0. 601, 0.866) | < 0.001 |
Intestinal wall enhancement | 0.370 (0.023, 0.764) | < 0.001 |
High density of the intestinal wall | 0.593 (0.297, 0.889) | < 0.001 |
Bowel dilation | 0.800 (0.672, 0.902) | < 0.001 |
Swelling and exudation in the mesentery | 0.859 (0.759, 0.959) | < 0.001 |
Seroperitoneum | 0.902 (0.818, 0.986) | < 0.001 |
Parenchymatous organ infarction | 0.960 (0.896, 1.000) | < 0.001 |
Table 3 Comparison of computed tomography subjective parameters between irreversible transmural intestinal necrosis and non-irreversible transmural intestinal necrosis groups, n (%)
CT signs | Total | ITIN | Non-ITIN | χ2 | P value |
Vascular CT sign | 62 | 29 | 33 | ||
SMA stenosis/occlusion involved range | 3.267 | 0.195 | |||
≤ 20 mm | 8 (12.9) | 2 (6.9) | 6 (18.2) | ||
20-50 mm | 16 (25.8) | 6 (20.7) | 10 (30.3) | ||
≥ 50 mm | 38 (61.3) | 21 (72.4) | 17 (51.5) | ||
SMA narrow/blocked area | 9.939 | 0.148 | |||
I | 5 (8.1) | 2 (6.9) | 3 (9.1) | ||
II | 0 (0) | 0 (0) | 0 (0) | ||
III | 2 (3.2) | 0 (0) | 2 (6.1) | ||
IV | 8 (12.9) | 1 (3.4) | 7 (21.2) | ||
I + II | 1 (1.6) | 0 (0) | 1 (3.0) | ||
III + IV | 24 (38.7) | 14 (48.3) | 10 (30.3) | ||
I + II + III | 4 (6.5) | 1 (3.4) | 3 (9.1) | ||
II + III + IV | 11 (17.7) | 6 (20.7) | 5 (15.2) | ||
I + II + III + IV | 7 (11.3) | 5 (17.2) | 2 (6.1) | ||
Intestinal wall CT sign | 102 | 48 | 54 | ||
Intestinal wall thickening | 62 (60.8) | 32 (66.7) | 30 (55.6) | 1.949 | 0.163 |
Reduced or absent bowel wall enhancement | 74 (72.5) | 43 (89.6) | 31 (57.4) | 4.543 | 0.033 |
Intestinal wall enhancement | 4 (3.9) | 0 (0) | 4 (7.4) | 0.122 | |
High density of the intestinal wall | 8 (7.8) | 4 (8.3) | 4 (7.4) | < 0.001 | 1 |
Bowel dilation | 47 (46.1) | 34 (70.8) | 13 (24.1) | 24.095 | < 0.001 |
Parenteral CT sign | |||||
Swelling and exudation in the mesentery | 61 (59.8) | 30 (62.5) | 31 (57.4) | 0.588 | 0.443 |
Seroperitoneum | 47 (46.1) | 24 (50.0) | 23 (42.6) | 0.872 | 0.350 |
Parenchymatous organ infarction | 45 (44.1) | 27 (56.3) | 18 (33.3) | 5.413 | 0.020 |
Table 4 Binary logistic regression analysis of factor influencing irreversible transmural intestinal necrosis in computed tomography subjective signs
CT signs | B value | Wald value | O1 | 95%CI | P value |
Reduced or absent bowel wall enhancement | 1.718 | 6.903 | 5.576 | 1.547-20.093 | 0.009 |
Bowel dilation | 2.452 | 18.420 | 11.613 | 3.790-35.586 | < 0.001 |
Parenchymatous organ infarction | 1.553 | 7.332 | 4.727 | 1.536-14.551 | 0.007 |
Table 5 Efficacy of computed tomography subjective signs to predict Irreversible transmural intestinal necrosis
CT signs | AUC (95%CI) | P value | Sensitivity (95%CI) | Specificity (95%CI) |
Reduced or absent bowel wall enhancement | 0.681 (0.581-0.769) | 0.002 | 91.67 (80.0-97.7) | 44.44 (30.9-58.6) |
Bowel dilation | 0.753 (0.658-0.833) | < 0.001 | 72.92 (58.2-84.7) | 77.78 (64.4-88.0) |
Parenchymatous organ infarction | 0.615 (0.513-0.709) | 0.046 | 56.26 (41.2-70.5) | 66.67 (52.5-78.9) |
Combination signs | 0.853 (0.769-0.915) | < 0.001 | 93.75 (82.8-98.7) | 64.81 (50.6-77.3) |
Table 6 Comparison of the efficacy of dual energy computed tomography objective indicators and computed tomography subjective signs in predicting Irreversible transmural intestinal necrosis
CT parameters | AUC (95%CI) | P value | Sensitivity (95%CI) | Specificity (95%CI) |
CT50 KeV normal/lesion | 0.794 (0.615-0.916) | 0.005 | 56.52 (34.5-76.8) | 87.50 (67.6-97.3) |
ICnormal/lesion | 0.777 (0.596-0.904) | 0.001 | 73.91 (51.6-89.8) | 79.17 (57.8-92.9) |
Combined subjective signs | 0.801 (0.622-0.920) | 0.006 | 80.95 (58.1-94.6) | 72.73 (39.0-94.0) |
CT50 KeV normal/lesion combined with intestinal dilatation and parenchymatous organ infarction | 0.857 (0.688-0.955) | 0.001 | 95.65 (78.1-99.9) | 79.17 (57.8-92.9) |
ICnormal/lesion combined with intestinal dilatation and parenchymatous organ infarction | 0.894 (0.737-0.976) | < 0.001 | 100 (85.2-100) | 70.83 (49.8-87.4) |
- Citation: Yang JS, Xu ZY, Chen FX, Wang MR, Fan XL, He BS. Diagnostic value of dual-energy computed tomography in irreversible transmural intestinal necrosis in patients with acute occlusive mesenteric ischemia. World J Gastrointest Surg 2025; 17(7): 105956
- URL: https://www.wjgnet.com/1948-9366/full/v17/i7/105956.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i7.105956